Modelling hepatitis C therapy—predicting effects of treatment
Crossref DOI link: https://doi.org/10.1038/nrgastro.2015.97
Published Online: 2015-06-30
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Perelson, Alan S.
Guedj, Jeremie
Text and Data Mining valid from 2015-06-30
Article History
First Online: 30 June 2015
Competing interests
: A.S.P and J.G. have consulted for Gilead Sciences. A.S.P has also consulted for Achillion Pharmaceuticals and Bristol-Myers Squibb.